• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,785
2,304
2,237
1,864
1,727

COUNTRY

1,033
871
272
254
210

CATEGORIES

  • 858
  • 186
  • 679
  • 1,127
  • 398
  • 270
  • 255
  • 66
  • 382
  • 725
  • 1,339
  • 1,356
  • 626
  • 884
  • 1,706
  • 2,689
  • 507
  • 732
  • 0
  • 93

PRICE

7,471
12,545
20,252
26,480

PUBLISHED

2,902
3,771
8,291
26,480

PRODUCT TYPE

21,606
2,901
872
827
164
44
21
21
17
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
IMS Pharmaceutical Pricing & Reimbursement Concise Guide: USA IMS Pharmaceutical Pricing & Reimbursement Concise Guide: USA - Product Thumbnail Image

IMS Pharmaceutical Pricing & Reimbursement Concise Guide: USA

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise...

September 2013

Psoriatic Arthritis Global Clinical Trials Review, H2, 2013

Psoriatic Arthritis Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Psoriatic Arthritis Global Clinical Trials Review, H2, 2013" provides data on the Psoriatic Arthritis...

September 2013
FROM

Gastroenteritis Global Clinical Trials Review, H2, 2013

Gastroenteritis Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Gastroenteritis Global Clinical Trials Review, H2, 2013" provides data on the Gastroenteritis clinical trial...

September 2013
FROM

Partnerships, Licensing, Investments and M&A Deals and Trends for 08, 2013 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for August 2013 in Pharmaceuticals Summary Our “Partnerships, Licensing, Investments and M&A Deals and Trends for August 2013 in Pharmaceuticals”...

September 2013
FROM

Hemoglobinuria Global Clinical Trials Review, H2, 2013

Hemoglobinuria Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Hemoglobinuria Global Clinical Trials Review, H2, 2013" provides data on the Hemoglobinuria clinical trial...

September 2013
FROM

Razadyne/Reminyl (Alzheimer's Disease) - Forecast and Market Analysis to 2022

Razadyne/Reminyl (Alzheimer’s Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Razadyne/Reminyl (Alzheimer’s Disease) -...

September 2013
FROM

Ulcerative Colitis Global Clinical Trials Review, H2, 2013

Ulcerative Colitis Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Ulcerative Colitis Global Clinical Trials Review, H2, 2013" provides data on the Ulcerative Colitis clinical...

September 2013
FROM

Menjugate (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Menjugate (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid...

September 2013
FROM

Vital Signs - The Global Market for Type 2 Diabetes Therapeutics

This issue of Vital Signs, released on September 30, 2013, provides a market overview and drug pipeline analysis of Type 2 diabetes therapeutics Additionally, a company spotlight is provided for Trovagene...

September 2013
FROM

PharmaPoint: Meningococcal Vaccines - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Meningococcal Vaccines - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Meningococcal Vaccines - France Drug Forecast...

September 2013
FROM

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India Summary GlobalData, the industry analysis specialist, has released its new report, “CountryFocus: Healthcare, Regulatory and...

September 2013
FROM

OpportunityAnalyzer: Opioid-Induced Constipation - Opportunity Analysis and Forecasts to 2017

OpportunityAnalyzer: Opioid-Induced Constipation - Opportunity Analysis and Forecasts to 2017 Summary The Opioid-Induced Constipation (OIC) is a new and rapidly establishing market currently dominated...

September 2013
FROM

PharmaPoint: Seasonal Influenza Vaccines - Global Drug Forecast and Market Analysis to 2022: Event-Driven Update

PharmaPoint: Seasonal Influenza Vaccines - Global Drug Forecast and Market Analysis to 2022: Event-Driven Update Summary Seasonal Influenza is a respiratory infection caused by influenza virus that...

September 2013
FROM

OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017

OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 Summary GlobalData has released its new report, “OpportunityAnalyzer: Nonalcoholic Steatohepatitis...

September 2013
FROM

Hot Trends in the Global Women's Health Ingredients Market

Due to the rising costs of healthcare, consumers have begun to adopt preventive solutions rather than relying on therapeutic intervention after the onset of disease Supplementing daily diets with health...

September 2013
FROM

Transforming Health Care Leadership. A Systems Guide to Improve Patient Care, Decrease Costs, and Improve Population Health

Praise for Transforming Health Care Leadership "The authors of this book provide the necessary tools for health care leaders to build a learning organization that can make the Triple Aim a reality?better...

September 2013

Health Care Information Systems. A Practical Approach for Health Care Management. 3rd Edition

This most widely used textbook in the field has been thoroughly revised and updated to reflect changes in the health care industry and the renewed focus on health care information technology initiatives....

September 2013
Vertex Pharmaceuticals' Cystic Fibrosis Franchise Vertex Pharmaceuticals' Cystic Fibrosis Franchise - Product Thumbnail Image

Vertex Pharmaceuticals' Cystic Fibrosis Franchise

Cystic fibrosis is caused by defects in the production, transport, and function of the CFTR sodium channels CFTR reside on cell surfaces where they regulate the concentrations of sodium and fluid within...

September 2013
FROM

US Medical Radiopharmaceuticals Market

This research service pertains to the US market for medical radiopharmaceuticals A thorough market sizing and forecasting model of market revenue, procedure volumes, and average pricing is included,...

September 2013
FROM
Antibody Fc: Antibody Fc: - Product Thumbnail Image

Antibody Fc:

Antibody Fc is the first single text to synthesize the literature on the mechanisms underlying the dramatic variability of antibodies to influence the immune response. The book demonstrates the importance...

September 2013
Loading Indicator

Our Clients

Our clients' logos